Roughly 10% of drugs that enter clinical trials get approved. Owkin believes agentic AI can help fix that

R&D World·Mar 30

This story is reported by R&D World. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Dynamic clinical trial success rates for drugs in the 21st century

Nature·Oct 29

2

Nearly 10% of internal medicine residents report having a disability

American Medical Association | AMA·Jun 18

3

Building biology-native data infrastructure for the AI era

Bessemer Venture Partners·Apr 13

4

China eclipses Europe for clinical trial starts: LEK report

BioWorld News·Dec 15

5

Lessons From Europe’s Loss of Biopharma Leadership, and Its Attempts to Recover | Reports & Briefings | Mar 18, 2026

Information Technology and Innovation Foundation (ITIF)·Mar 18

6

2026 is the year of obesity pills. Here's how they could reshape the GLP-1 market

CNBC·Jan 10

7

Analysis of phase II and phase III clinical trial terminations from 2013 to 2023

Nature·Dec 18

8

Editas Medicine: Resetting Pipeline Just To Be Second To Market Again (NASDAQ:EDIT)

Seeking Alpha·May 28